Citation Information :
Aggarwal V, Kundal M. MIS-C is a Clinically Different Entity from Acute COVID-19 in Adults. Indian J Crit Care Med 2021; 25 (8):954-955.
Mehra B, Aggarwal V, Kumar P, Kundal M, Gupta D, Kumar A, et al. COVID-19 associated severe multisystem inflammatory syndrome in children with encephalopathy and neuropathy in an adolescent girl with the successful outcome: an unusual presentation. Indian J Crit Care Med 2020; 24(12):1276–1278. DOI: 10.5005/jp-journals-10071-23685.
Kabeerdoss J, Pilania RK, Karkhele R, Kumar TS, Danda D, Singh S. Severe COVID-19, multisystem inflammatory syndrome in children, and Kawasaki disease: immunological mechanisms, clinical manifestations and management. Rheumatol Int 2021; 41(1):19–32. DOI: 10.1007/s00296-020-04749-4.
Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, et al. Diagnosis and management of Guillain–Barré syndrome in ten steps. Nat Rev Neurol 2019; 15(11):671–683. DOI: 10.1038/s41582-019-0250-9.
Lee YJ. Acute disseminated encephalomyelitis in children: differential diagnosis from multiple sclerosis on the basis of clinical course. Korean J Pediatr 2011; 54(6):234–240. DOI: 10.3345/kjp.2011.54.6.234.
Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome. Lancet 2021;397(10280):1214–1228. DOI: 10.1016/S0140-6736(21)00517-1.
Alsaied T, Tremoulet AH, Burns JC, Saidi A, Dionne A, Lang SM, et al. Review of cardiac involvement in multisystem inflammatory syndrome in children. Circulation 2021; 143(1):78–88. DOI: 10.1161/CIRCULATIONAHA.120.049836.
Dionne A, Dahdah N. A decade of NT-proBNP in acute Kawasaki disease, from physiological response to clinical relevance. Children 2018; 5(10):141. DOI: 10.3390/children5100141.
